1. Home
  2. JFIN vs RCEL Comparison

JFIN vs RCEL Comparison

Compare JFIN & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JFIN
  • RCEL
  • Stock Information
  • Founded
  • JFIN 2011
  • RCEL 2020
  • Country
  • JFIN China
  • RCEL United States
  • Employees
  • JFIN N/A
  • RCEL N/A
  • Industry
  • JFIN Finance: Consumer Services
  • RCEL Medical/Dental Instruments
  • Sector
  • JFIN Finance
  • RCEL Health Care
  • Exchange
  • JFIN Nasdaq
  • RCEL Nasdaq
  • Market Cap
  • JFIN 335.7M
  • RCEL 342.7M
  • IPO Year
  • JFIN 2019
  • RCEL N/A
  • Fundamental
  • Price
  • JFIN $6.26
  • RCEL $11.77
  • Analyst Decision
  • JFIN
  • RCEL Hold
  • Analyst Count
  • JFIN 0
  • RCEL 3
  • Target Price
  • JFIN N/A
  • RCEL $16.50
  • AVG Volume (30 Days)
  • JFIN 46.0K
  • RCEL 96.7K
  • Earning Date
  • JFIN 11-20-2024
  • RCEL 02-20-2025
  • Dividend Yield
  • JFIN 14.38%
  • RCEL N/A
  • EPS Growth
  • JFIN N/A
  • RCEL N/A
  • EPS
  • JFIN 3.08
  • RCEL N/A
  • Revenue
  • JFIN $854,955,021.00
  • RCEL $60,040,000.00
  • Revenue This Year
  • JFIN N/A
  • RCEL $40.34
  • Revenue Next Year
  • JFIN N/A
  • RCEL $52.79
  • P/E Ratio
  • JFIN $2.03
  • RCEL N/A
  • Revenue Growth
  • JFIN 21.87
  • RCEL 32.24
  • 52 Week Low
  • JFIN $4.00
  • RCEL $7.51
  • 52 Week High
  • JFIN $8.58
  • RCEL $18.93
  • Technical
  • Relative Strength Index (RSI)
  • JFIN 45.24
  • RCEL 43.48
  • Support Level
  • JFIN $6.28
  • RCEL $11.30
  • Resistance Level
  • JFIN $6.85
  • RCEL $12.75
  • Average True Range (ATR)
  • JFIN 0.31
  • RCEL 0.74
  • MACD
  • JFIN -0.00
  • RCEL -0.24
  • Stochastic Oscillator
  • JFIN 13.33
  • RCEL 18.01

About JFIN Jiayin Group Inc.

Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital + technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: